Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
206 Ortho, Inc. currently manages 3 pending office actions within the Chemistry & Materials technology area. These actions are distributed across 2 distinct art units. The portfolio involves 3 distinct examiners, ensuring that no individual handles all of the company's active matters.
Lynda Salvatore is identified as the busiest examiner for this portfolio, currently overseeing 1 pending office action. This distribution shows that the workload is spread among the various officials involved in the company's patent applications.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (50%) |
| Double-patenting only | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JONES, DIANA S | 1 | 75.1% | +20.2% |
| SALVATORE, LYNDA | 1 | 64.1% | +19.4% |
| HAGOPIAN, CASEY SHEA | 1 | 54.4% | +33.3% |
| MCKINNON, LASHAWNDA T | 1 | 53.9% | +30.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18952673 | DEGRADABLE COMPOSITE AND METHOD OF FABRICATION | JONES, DIANA S | 74d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17776581 | METHOD AND APPARATUS FOR DESIGNS, MATERIALS, AND METHODS OF MANUFACTURING COMPOSITE MATERIALS AND IMPLANTS | MCKINNON, LASHAWNDA T | 145d overdue |
| 18952673 | DEGRADABLE COMPOSITE AND METHOD OF FABRICATION | JONES, DIANA S | 74d overdue |
| 18252849 | ELONGATED COMPOSITE FOR AN IMPLANT | HAGOPIAN, CASEY SHEA | 74d overdue |
| 18515020 | DEGRADABLE COMPOSITE AND METHOD OF FABRICATION | SALVATORE, LYNDA | — |
| Art Unit | Apps |
|---|---|
| 1789 | 2 |
| 3775 | 1 |
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18952673 | DEGRADABLE COMPOSITE AND METHOD OF FABRICATION | JONES, DIANA S | 3775 | §102§112 | Final Rejection | 74d overdue | Pending | Nov 19, 2024 |
| 18515020 | DEGRADABLE COMPOSITE AND METHOD OF FABRICATION | SALVATORE, LYNDA | 1789 | DP | Final Rejection | — | Pending | Nov 20, 2023 |
| 18252849 | ELONGATED COMPOSITE FOR AN IMPLANT | HAGOPIAN, CASEY SHEA | 1617 | §112 | Final Rejection | 74d overdue | Pending | May 12, 2023 |
| 17776581 | METHOD AND APPARATUS FOR DESIGNS, MATERIALS, AND METHODS OF MANUFACTURING COMPOSITE MATERIALS AND IMPLANTS | MCKINNON, LASHAWNDA T | 1789 | §112 | Non-Final OA | 145d overdue | Pending | May 12, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial